Searched for
KYPROLIS
Natco Pharma's marketing partner gets USFDA nod for anti-cancer drugNatco Pharma said based on the ANDA filing date, the company believes that it is eligible for 180 days of sole generic marketing exclusivit...- Natco, Onyx settle cancer drug patent litigationThe Indian generic drug maker had partnered with Breckenridge Pharmaceutical for marketing its Carfilzomib injection in the US market.
- Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.
- Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...
- Dr Reddy's Lab shares up almost 2% on boursesShares of Dr Reddy's Laboratories rose almost 2% after the company said it has inked a pact with US-based biotechnology firm Amgen to marke...
- Dr Reddy's to market three Amgen drugs in IndiaDr Reddy's Laboratories today said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs.
Load More